Soleno Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLNO and other ETFs, options, and stocks.

About SLNO

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder.

CEO

Anish Bhatnagar

CEOAnish Bhatnagar

Employees

Employees42

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

1999

Founded1999

Employees

Employees42

SLNO Key Statistics

Market cap

1.21B

Market cap1.21B

Price-Earnings ratio

-12.49

Price-Earnings ratio-12.49

Dividend yield

—

Dividend yield—

Average volume

273.33K

Average volume273.33K

High today

$37.90

High today$37.90

Low today

$36.86

Low today$36.86

Open price

$36.86

Open price$36.86

Volume

52.12K

Volume52.12K

52 Week high

$53.82

52 Week high$53.82

52 Week low

$3.16

52 Week low$3.16

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

Soleno Therapeutics

Why Robinhood?

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. Show more

SLNO Key Statistics

Analyst ratings

100%

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder.